FibroBiologics, Inc. (FBLG) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 | Khoja Hamid Chief Scientific Officer | $500,001 | 597,016 | New | No | |
|
|
||||||
| June 23, 2026 | Hoffman Robert E. Director | $0 | 30,803 | 0% | No | |
|
|
||||||
| June 23, 2026 | Cilento Richard C. Jr. Director | $0 | 30,803 | 0% | No | |
|
|
||||||
| June 23, 2026 | Link Matthew Director | $0 | 30,803 | 0% | No | |
|
|
||||||
| June 23, 2026 | Niklas Victoria Ninon Olivia Director | $0 | 30,803 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free